Can technetium 99m pyrophosphate be used to quantify myocardial injury in donor hearts?

Citation
Cmr. Satur et al., Can technetium 99m pyrophosphate be used to quantify myocardial injury in donor hearts?, ANN THORAC, 68(6), 1999, pp. 2225-2230
Citations number
19
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Journal title
ANNALS OF THORACIC SURGERY
ISSN journal
00034975 → ACNP
Volume
68
Issue
6
Year of publication
1999
Pages
2225 - 2230
Database
ISI
SICI code
0003-4975(199912)68:6<2225:CT9PBU>2.0.ZU;2-A
Abstract
Background. There are no prospective methods available to quantify the myoc yte injury in hearts prior to transplantation. The potential of the isotope labeled infarct marker 99m Technetium pyrophosphate (TcPPT) being used in this role was investigated. Methods. Brain death was induced by creating an extradural space occupying lesion in young adult swine after which hemodynamic changes were monitored and myocyte injury was quantified by histochemistry. TcPPT was administered 5 hours after induction of intracranial hypertension, and after hearts wer e harvested myocardial uptake was measured. These latter measurements were related to the histochemical assessment of myocyte injury. Results. Sham animals (n = 4) maintained cardiovascular stability and exper ienced minimal myocyte injury, grades 0 to 3. ED animals (n = 10) exhibited varying patterns of hemodynamic change and myocyte injury, the latter was significant in 6, graded 4 to II, p less than 0.05. Uptake of TcPPT by ED h earts was greater than twice the 90th centile sham value in 6. The sensitiv ity and specificity of greater uptake indicating the presence of myocyte in jury was 83.3% and 75% respectively. Conclusions. TcPPT has the potential to quantify myocardial injury induced by brain death and its potential utility merits further investigation. (C) 1999 by The Society of Thoracic Surgeons.